Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections.
Polymer-augmented liposomes enhancing antibiotic delivery against intracellular infections.
复制标题
DOI:
10.1039/c8bm00282g
复制
发表时间:
2018-06-25
影响因子:
6.6
通讯作者:
Stayton PS
中科院分区:
文献类型:
--
作者:
Su FY ;Chen J ;Son HN ;Kelly AM ;Convertine AJ ;West TE ;Skerrett SJ ;Ratner DM ;Stayton PS
Pulmonary intracellular infections, such as tuberculosis, anthrax, and tularemia, remain a significant challenge to conventionl antibiotic therapy. Ineffective antibiotic treatment of these infections can lead not only to undesired side effects, but also the emergence of antibiotic resistance. Aminoglycosides (e.g., streptomycin) have long been part of the therapeutic regiment for many pulmonary intracellular infections. Their bioavailability for intracellular bacterial pools, however, is limited by poor membrane permeability and rapid eliminaton. To address this challenge, polymer-augmented liposomes (PALs) were developed to provide improved cytosolic delivery of streptomycin to alveolar macrophages, an important host cell for intracellular pathogens. A multifunctional diblock copolymer was engineered to functionalize PALs with carbohydrate-mediated targeting, pH-responsive drug release, and endosomal release activity with a single functinoal polymer that replaces the pegylated lipid component to simplify the liposome formulation. The pH-sensing functionality enabled PALs to provide enhanced release of streptomycin under endosomal pH condition (70% release in 6 hours) with limited release at physiological pH 7.4 (16%). The membrane-destabilizing activity connected to endosomal release was characterized in a hemolysis assay and PALs displayed a sharp pH profile across the endosomal pH development target range. The direct connection of this membrane-destalizing pH profile to model drug release was demonstrated in an established pyranine / p-xylene bispyridinium dibromide (DPX) fluorescent dequenching assay. PALs displayed similar sharply pH-responsive release, whereas PEGylated control liposomes did not, and similar profiles were then shown for streptomycin release. The mannose-targeting capability of the PALs was also demonstrated with 2.5 times higher internalization compared to non-targeted PEGylated liposomes. Finally, the streptomycin-loaded PALs was shown with a significantly improved intracellular antibacterial activity in a Francisella-macrophage co-culture model, compared with free streptomycin or streptomycin delivered by control PEGylated liposomes (13× and 16×, respectively). This study suggests the potential of PALs as a useful platform to deliver antibiotics for the treatment of intracellular macrophage infections. A simplified liposome formulation with three functionalities to enhance antibiotic bioavailability to cytosolic bacteria: carbohydrate-mediated targeting; pH-responsive release; endosomal-releasing activity.
登录
查看更多内容
DOI:
10.1016/j.jconrel.2008.10.004
发表时间:
2009-02-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Convertine AJ;Benoit DS;Duvall CL;Hoffman AS;Stayton PS
通讯作者:
Stayton PS
影响因子:
4.7
作者:
Kobayashi, Sachiko;Nakase, Ikuhiko;Futaki, Shiroh
通讯作者:
Futaki, Shiroh
影响因子:
5.5
作者:
KITANO, H;AKATSUKA, Y;ISE, N
通讯作者:
ISE, N
DOI:
10.1016/j.jconrel.2014.03.041
发表时间:
2014-10-10
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Keller S;Wilson JT;Patilea GI;Kern HB;Convertine AJ;Stayton PS
通讯作者:
Stayton PS
影响因子:
4.6
作者:
Lane DD;Su FY;Chiu DY;Srinivasan S;Wilson JT;Ratner DM;Stayton PS;Convertine AJ
通讯作者:
Convertine AJ